Joyce LinAssociate DirectorTrillium Therapeutics
Joyce Lin, CPA, CA is Associate Director, Finance at Trillium Therapeutics, a clinical stage immuno-oncology company, which develops innovative therapies for the treatment of cancer (acquired by Pfizer in 2021). At Trillium Therapeutics, Joyce leads end-to-end finance functions, including operations, budgeting, financial reporting, internal controls, financing, and compliance. Prior to joining Trillium Therapeutics in 2014, Joyce led audit engagements at Deloitte LLP with various privately held companies, not-for-profit organizations, governments, and publicly traded entities.
Joyce holds a Master of Accounting degree and a Bachelor of Science in Biotechnology/Chartered Accountancy, both from the University of Waterloo.